anemia presentation
TRANSCRIPT
![Page 2: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/2.jpg)
Normocytic anaemia
Presented by :-Dr.Tahira Zainab
![Page 3: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/3.jpg)
Normocytic anaemia:-Normocytes
Normal sized cell
Normal MCV (80-96fL)
Acute blood lossanaemia of chronic
diseaseRenal failureAutoimmune
rheumatic feverMarrow
infilteration/fibrosisEndocrine disease Haemolytic anmia
![Page 4: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/4.jpg)
Haemolytic anaemia:-
• anaemia caused by increased destruction of red blood cells.
• Life span of RBC’s decreased from 120 to fewer days.
• Break down occurs in macrophages of bone marrow,liver and spleen.
![Page 5: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/5.jpg)
Sites of haemolysis:-
• Extravascular haemolysis• Most common; spleen and liver macrophages are sites
of destruction.
• Intravascular haemolysis• Hemoglobin is liberated and binds to hepatolobulins• Deposited as hemosiderin• Hemosiderin excreted in urine• Free Hb oxidized to methaemoglobulin
spectrophotometry of plasma forms bands;schumm’s test.
![Page 6: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/6.jpg)
Evidence of haemolysis
• Radioisotop labled red cells 51c labelled red cells• Raised plasma Hb levels• Haemosiderinuria• Low haptoglobins• Schumm’s test
• Compensated haemolytic anaemia erythroid hyperplasia
• Reticulocytes increased in peripheral blood film.
Consequences:-
![Page 7: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/7.jpg)
Causes:-Inherited Acquired
Red cell membrane defect Immune
Hereditary spherocytosis Autoimmune, warmHereditary eliptocytosis ColdHaemoglobinopathies Alloimmune
Thalassaemia Haemolytic transfusion reactionSickle cell disease Haemolytic disease of newbornMetabolic defects Allogenic bone marrow transplantation
G6PD deficiency Drug induced
Pyruvate kinase deficiency Non immune
Pyrimidine kinase deficiency Acquired membrane defects paroxysmal nocturnal haemoglobinuriaMiscllaneousMechanicalInfections e.g. malaria
Drugs Renal and liver disease
![Page 8: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/8.jpg)
Inherited:-
• Red cell membrane defects
– Hereditary spherocytosis
– Hereditary eliptocytosis
![Page 9: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/9.jpg)
Hereditary spherocytosis:-
• Most common hereditary hemolytic anaemia• Due to deficiency of structural protein Ankyrin
commonly and spectrin.• Fragile and spherical cells destructed in spleen
![Page 10: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/10.jpg)
Clinical Features:-
• Jaundice may be present at birth or delayed for years or asymptomatic throughout life.
• Symptomatic patients develop anaemia,spleenomegaly and ulcers on legs.
• Haemolysis pigmented gallstones
![Page 11: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/11.jpg)
Investigation:-
• Mild anaemia• Blood film shows spherocytes• Serum birlirubin and urinary urobilinogen will
be raised• Osmotic fragility• Direct antiglobulin (coomb’s test) Is negetive
![Page 12: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/12.jpg)
Treament:-
• Raised bilirubin,gallstones present splenectomy
• Postponed in until after childhood• Preceded by immunization and lifelong
penicillin• Spherocytes persist but Hb normal• Prophylactic folate supplements
![Page 13: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/13.jpg)
Hereditary eliptocytosis:-
• Milder than spherocytosis• Deficiency of protein spectrin/actin 4.1
complex leading to weakness of horizontal protein interaction
• Requires spleenctomy in severe cases
![Page 14: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/14.jpg)
Hereditary stomatocytosis:-
• Red cells in which pale central area appears slit like
• Rare condition, alcohol is one of causes• Spleenectomy contraindicated as it may leade
to severe thromboembolic events.
![Page 15: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/15.jpg)
Haemoglobinopathies:-
– Thalassaemia
– Sickle cell anaemia
• Already discussed
![Page 16: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/16.jpg)
Metabolic defects:-
– G6PD deficiency
– Pyruvate kinase deficiency
– Pyrimidine 5’ nucleotidase deficiency
![Page 17: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/17.jpg)
Normal metabolism:-
• ATP required for membrane integrity,shape maintanace and other works is obtained via
• Glycolytic pathway 90%• HMP shunt 10%
• In addition to provide ATP;HMP shut provides reducing power in form of NADPH (enzyme required G6PD)– Maintains reduced glutathion to combate oxidative stress
• Combates oxidative stress and prevents Hb oxidation to • methaemoglobin;that precipitates as heinz bodies
![Page 18: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/18.jpg)
G6PD deficiency:-• Required to convert NADP to NADPH;• Common condition presenting as hemolytic anaemia• Gene involved is on X chromosome;that’s why more
common in males• Over 400 structural types• On severity of haemolysis and enzyme deficiency WHO
classified variants;common are…• African or milder type A ;haemolysis only in older cells,self
limiting haemolysis b/c new cells have sufficient enzyme• Mediterranean or B type; severe deficinecy
![Page 19: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/19.jpg)
Clinical syndromes:-
• Acute drug induced haemolysis• Chronic haemolytic anaemia• Neonatal jaundice• Precipitated by infection• In all conditions presents as anaemia,jaundice
and haemoglobinuria
![Page 20: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/20.jpg)
Investigation:-
• Blood counts normal between attacks
• During attacks;– Blood film shows; bite
cells,blister cells,heinz bodies
– reticulocytosis• Evident haemolysis• Enzyme assay
![Page 21: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/21.jpg)
Treatment:-
• Offending drug should be stopped
• Infections treated• Blood transfusion
may be life-saving• Splenectomy not
usualy required
![Page 22: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/22.jpg)
Pyruvate kinase deficiency:-
• Common after G6PD deficiency• Presents as anaemia and blood film
disorders,pyruvate kinase activity low• Treated by blood transfusion• Splenectomy in severe cases
![Page 23: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/23.jpg)
Pyrimidine 5’ nucleotidase deficiency:-
• Enzyme required for RNA degradation in reticulocytes to remove residues of RNA
• Deficiency causes basophilic stipling of RBC’s• Enzyme also inhibited by lead• Causes haemolytic anaemia
![Page 24: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/24.jpg)
Acquired hemolytic anaemias:-
– Immune
– Non immune
![Page 25: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/25.jpg)
Immune:-
– Autoimmune• Warm and cold
– Alloimmune• HDN (haemolytic disease of newborn)
– Drud induced
![Page 26: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/26.jpg)
Immune:-
• Autoimmune Haemolytic anaemia (AIHA):-– Increased cell destruction because of red cell
autoantibodies– Antibodies detected on cell surface (coomb’s test)– Depending on if antibodies attaches to cell at 37 Oc
or at lower temperature AIHA divided into cold and warm types
– Destruction may be complement mediated (by lysis complex) or phagocytesed by macrophages.
![Page 27: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/27.jpg)
Warm autoantibodies:-
• IGg predominantly• Direct antiglobin test positive with IGg
alone,IGg and compliment ,or complement alone
![Page 28: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/28.jpg)
Clinical features:-
• Middle aged female common but can occur in both sexes at any age
• Short episodes of anemia• Remintting and relapsing jaundice• Intermittent chronic pattern• Spleen palpable• May be associated with WBC’s malignancy
Rheumatoid arthritis,SLE or drugs
![Page 29: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/29.jpg)
Investigations:-
• Evidence of haemolysis• Spherocytes present• Coomb’s test positive• Autoimmune thrombocytopenia may be
present
![Page 30: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/30.jpg)
Treatment:-
• Corticosteroids; e.g. prednisolone 1mg/kg daily effective 80%– Reduced antibody formation– Reduced RBC destruction
• Splenectomy in no response to steroids• Immunosupperssive e.g. azathioprine• Blood transfustion
![Page 31: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/31.jpg)
Cold autoantibodies:-
• Agglutinins reacting at 40C• Harmless usualy. At low temperature presents
just like warm antibodies present as.
![Page 32: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/32.jpg)
Drug induced haemolytic anaemia:-
• Interaction between drug and cell membrane,three types of intraction– Antiboies to drug only;quinidine,rifampicin:-
resolves when drug withdrawn– Antibodies to cell membrane only;methyldopa– Antibodies to both; e.g. penicillin
![Page 33: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/33.jpg)
Alloimmune haemolytic anaemia:-
• Antibodies produced in one individual react with the red cells of another. Occurs in;
• Haemolytic disease of newborn• Transfusion reactions• Allogenic transplants of bone
marrow,liver,heart,kidney.
![Page 34: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/34.jpg)
Haemolytic disease of newborn (HDN):-
• HDN due to fetomaternal incompatibility for red cell antigens.
• Maternal antibodies only IGg cross placenta and destroy fetal red cells.
• Common types• ABO type common but milder;mother is O and fetus A• RhD incompatibility less common b/c of anti-D
prophylaxis
![Page 35: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/35.jpg)
Note:-
• Fetal blood cells that enter maternal circulation at time of delivery caus maternal immune activation against antigens and antibody formation
• Thus chances of HDN for the next babies increase
• 1st is baby usually spared.
![Page 36: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/36.jpg)
Clinical features:-
• May Presents as• Mild anaemia to• Intrauterine death from 18 weeks;hydrops fetalis
(hepatosplenomegaly,oedema and cardiac failure)• Kernicterus owing to severe jaundice,unconjugated
billirubin exceeding 250 µmol/L,bile deposition in basal ganglia• Permanent brain damage,spacticity• May present as deafness
![Page 37: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/37.jpg)
Investigation:-
• Routine antenatal serology;• ABO and RhD group determined of all mothers and
repeated at 28 weeks
![Page 38: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/38.jpg)
Postnatal care:-
• Mild cases phototherapy• Severe case; exchange transfusion indication
• Note:- blood used should be ABO compatible with mother and fetus and should lack antigen against which mother antibody is directed.
![Page 39: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/39.jpg)
Prevention of RhD incompatibility HDN:-• Anti-D should be given to mother after delivery
when all of following present;– Mother is RhD negative– Father is RhD positive– Mother immune system not yet activated against antigen
• Dose is 500 i.u of IGg anti-D intramuscularly within 72 hours of delivery.
![Page 40: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/40.jpg)
Non immune:-
– Acquired membrane defects• Paroxysmal nocturnal haemoglobinuria
– Mechanical– Systemic disease
![Page 41: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/41.jpg)
Paroxysmal nocturnal haemoglobinuria:-
• Urine voided at night and morning is dark colored, cause of this timing not known
• Is caused by defective gene of proteins required for complement degradation continued complement degradation of RBC’s
![Page 42: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/42.jpg)
![Page 43: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/43.jpg)
Clinical feature:-
• Major clinical signs intravascular haemolysis , venous thrombosis, haemoglobinuria
• In severs cases all urine samples dark• Iron deficiency• Budd-chiari syndrome venous thrombosis in
liver• Thrombosis at other sites like GI,brain
![Page 44: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/44.jpg)
Investigation:-
• Intravenous haemolysis evident– Radioisotop labled red cells 51c labelled red cells– Raised plasma Hb levels– Haemosiderinuria– Low haptoglobins– Schumm’s test
• Flow cytometric analysis of red cells with anti-CD55 and anti-CD59
• Bone marrow hypoplastic (exhuastion)
![Page 45: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/45.jpg)
Treatment:-
• Chronic disorder requires supportive measures– Leukocyte depleted blood transfusion– Eculiczumab (prevent c5 cleavage)
• Long term– Anticoagulants (venous thrombosis)
• Bone marrow aplasia cases– Immunosuppression with antilymphocyte globulin or
bone marrow transplant ; survival 10-15 years• Note:- may lead to acute leukemia
![Page 46: Anemia Presentation](https://reader035.vdocuments.us/reader035/viewer/2022062522/58e77c201a28ab4d5a8b4695/html5/thumbnails/46.jpg)
Thank you all…